Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by McGill University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Jewish General Hospital
Information provided by:
McGill University
ClinicalTrials.gov Identifier:
NCT01374100
First received: April 13, 2011
Last updated: June 14, 2011
Last verified: February 2011

April 13, 2011
June 14, 2011
February 2009
June 2011   (final data collection date for primary outcome measure)
  • Change in Depression and Anxiety [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Depression and anxiety will be measured using the Hospital Anxiety Depression Scale (HADS); The HADS is a 14-item self-rated questionnaire, consisting of two 7-item subscales. It was developed to identify anxiety and depression in non-psychiatric medical outpatients. Each item on the HADS is scored from 0 (no problem) to 3 (maximum distress). The HADS will be administered within 2 weeks of completing each exercise program.
  • Change in Quality of Life (QoL) [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    The general version of the Functional Assessment of Cancer Therapy scale (FACT-G) will be used to measure Quality of Life (QoL) after completion of each 6 week exercise program. This questionnaire consists of 4 subscales: Physical well-being (PWB), Social well-being (SWB), Emotional well-being (EWB) and Functional well-being (FWB). A change of 4 points on the total FACT score is regarded as clinically significant.
Same as current
Complete list of historical versions of study NCT01374100 on ClinicalTrials.gov Archive Site
  • Change in functional capacity [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Functional capcity will be measured using the Simmonds Functional Assessment (SFA) within 2 weeks of finishing each 6-week exercise program. This tool consists of eight items: putting on a sock, tying a belt, putting coins in a cup, reaching forward, repeated reach up (3 times), repeated sit to stand (2 times), speed walk for 50 feet, and walking for 6 minutes. Patient satisfaction will be measured by asking all participants to answer a two item questionnaire with a 10-point visual analog scale response option.
  • Change in cancer Symptoms [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Symptoms commonly reported by lung and GI cancer patients will be measured using the Edmonton Symptom Assessment Scale (ESAS). The ESAS is a 12-item patient rated symptom questionnaire scored using a 10-point visual analogue scale. The ESAS will be administered within 2 weeks of completing each 6-week exercise program.
  • Program Satisfaction [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Patient satisfaction will be measured by asking all participants to answer a two-item questionnaire after they have completed each 6-week exercise program.
Same as current
Not Provided
Not Provided
 
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
Effect of Qigong Therapy in Patients With Advanced NSCLC and GI Cancer Undergoing Chemotherapy

Cancer patients face a number of symptoms related to treatment or disease which may impair quality of life, such as decreased functional capacity, fatigue, nausea an vomiting, distress, depression and unmet psychological needs. Due to this array of symptoms, cancer patients often seek supportive complementary and alternative medicine, which many patients use along with conventional treatments. Qigong, a type traditional chinese medicine, is a mind-body exercise that combines meditation, slow physical movements, and controlled breathing. The investigators hypothesise that Qigong therapy is better in the reduction of anxiety and depression levels and the improvement of quality of life in patients with lung and gastrointestinal (GI) cancer who are eligible for anti-cancer treatment, when compared to standard exercise training.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
  • Carcinoma, Non-Small-Cell Lung
  • Cancer of the Gastrointestinal Tract
  • Behavioral: Standard Exercise
    The standard exercise therapy program will include 12 treatments of approximately 45 minutes duration, twice a week for a period of six weeks by the same instructor and at the same location as for Qigong therapy. This exercise program is supervised and consists of cardio-vascular and resistance training exercises. Participants are asked to refrain from practicing Qigong during this 6 week period.
  • Behavioral: Qigong Exercise
    Qigong therapy will be led by a trained Qigong instructor and will occur for 45 minutes sessions, twice a week for a period of six weeks. Qigong is a self-directed walking exercise program that involves arm movements that are coordinated with slight movements of the waist, while in a state of deep relaxation or meditation. Patients will be asked to refrain from independent resistance or cardiovascular training during this 6 week period.
  • Active Comparator: Standard Excercise
    Intervention: Behavioral: Standard Exercise
  • Experimental: Qigong exercise
    Intervention: Behavioral: Qigong Exercise
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
52
December 2012
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. A pathologically (histological or cytological) confirmed clinical diagnosis of non-small cell lung cancer (NSCLC) or GI cancer
  2. Stage 3 or 4 disease and eligible for anti-cancer treatment
  3. Performance status (PS) of 0 - 2 as determined by the Eastern Cooperative Oncology Group-Performance Status
  4. Life expectancy estimated at > 4 months
  5. Age 18 years or older
  6. Willing and able to provide informed consent
  7. Must be approved for participation by the oncology treatment team
  8. Able to communicate in French or English

Exclusion Criteria:

  1. Contraindication to exercise as determined by the oncology treatment team
  2. Severe cardiac or neuro-muscular/skeletal disease
  3. Engaging in interventions to address anxiety or depressive symptoms
  4. Brain metastases
  5. Active psychiatric conditions
  6. Pregnant or breast-feeding mothers
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT01374100
08-068
Yes
Dr. Thomas Jagoe, Cancer Nutrition Rehabilitation Program
McGill University
Jewish General Hospital
Principal Investigator: Thomas Jagoe, MD, PhD McGill, Cancer Nutrition Rehabilitation Program
McGill University
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP